NCT04068168Completed
Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS)
Source: ClinicalTrials.gov · Last updated 17 Nov 2025
Brief summary (registry, in English)
The objectives of this study are to assess safety and efficacy of Imfinzi (durvalumab) in a real world setting in patients treated with Imfinzi under the approved indication in Korea.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 712 (actual)
- First submitted
- 7 Aug 2019
- Start date
- 30 Jan 2020
- Primary completion date
- 27 Dec 2024
- Lead sponsor
- AstraZeneca
- NCT number
- NCT04068168
What you commit to
- Study type: Observational
- Participants enrolled: 712
- From 30 Jan 2020 to the primary completion date, 27 Dec 2024
- 24 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Current participation in any interventional trial
- Other off-label indications according to the approved label
Who the study is looking for
- Eligible for Imfinzi treatment according to the approved label
- Provision of signed and dated written informed consent by the patient or legally acceptable representative
Sex: All · Does not accept healthy volunteers
Sites (24)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Research Site Coordinator of this site? Confirm its status | Anyang-si | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Bucheon-si | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Busan | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Changwon | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Changwon-si | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Cheonan | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Chuncheon | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Daegu | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Daejeon | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Goyang-si | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Gwangju | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Hwasun-gun | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Iksan-si | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Incheon | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Jeju-do | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Jeonju | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Pohang-si | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Seongnam-si | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Suwon | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Uijeongbu-si | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Wŏnju | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Yangsan | South Korea | Unknown status |
| Research Site Coordinator of this site? Confirm its status | Yongin-si | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.